Topic: Neonatal Abstinence Syndrome

If you do not find what you are looking for try searching with a different term or contact us.

Neonatal Opioid Withdrawal Syndrome

This website, from the Cleveland Clinic, provides comprehensive information on Neonatal Opioid Withdrawal Syndrome (formerly Neonatal Abstinence Syndrome), covering its causes, symptoms, diagnosis, treatment, prevention, and outlook.

Neonatal Abstinence Syndrome

Neonatal abstinence syndrome (NAS) is a spectrum of clinical manifestations seen in neonates due to withdrawal secondary to intrauterine drug exposure. It is most commonly associated with maternal opioid use and can be complicated by intrauterine exposure to benzodiazepines, alcohol, and various other drugs. The incidence of NAS has continued to rise in recent years, highlighting the need for providers to be able to recognize and appropriately manage the complications. There is significant long-term neurodevelopmental morbidity and mortality among NAS babies. This activity reviews the evaluation and management of NAS and highlights the interprofessional healthcare team’s role in improving care for patients with this complex condition.